Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
Ligand Pharmaceuticals (LGND) - Total assets
Total assets on the balance sheet as of December 2023 : $0.78 B
According to Ligand Pharmaceuticals's latest financial reports the company's total assets are $0.78 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.78 B | 3.22% |
| 2022-12-31 | $0.76 B | -41.22% |
| 2021-12-31 | $1.29 B | -4.75% |
| 2020-12-31 | $1.36 B | -8.87% |
| 2019-12-31 | $1.49 B | 18.57% |
| 2018-12-31 | $1.26 B | 87.89% |
| 2017-12-31 | $0.67 B | 11.54% |
| 2016-12-31 | $0.60 B | 19.58% |
| 2015-12-31 | $0.50 B | 94.96% |
| 2014-12-31 | $0.25 B | 146.42% |
| 2013-12-31 | $0.10 B | 0.43% |
| 2012-12-31 | $0.10 B | -13.54% |
| 2011-12-31 | $0.12 B | 59.59% |
| 2010-12-31 | $75.55 M | -46.72% |
| 2009-12-31 | $0.14 B | -17.29% |
| 2008-12-31 | $0.17 B | -1.06% |
| 2007-12-31 | $0.17 B | -46.86% |
| 2006-12-31 | $0.32 B | 3.63% |
| 2005-12-31 | $0.31 B | -5.37% |
| 2004-12-31 | $0.33 B | 5.87% |
| 2003-12-31 | $0.31 B | 14.02% |
| 2002-12-31 | $0.27 B | 134.46% |
| 2001-12-31 | $0.11 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 21,184.88% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 28,672.41% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 8,030.72% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 12,241.47% | 🇺🇸 USA |
 Baxter BAX | $28.27 B | 3,491.90% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 13,450.92% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 12,479.90% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 9,441.65% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $0.10 B | -86.32% | 🇺🇸 USA |